Literature DB >> 20425235

Spinal muscular atrophy: new and emerging insights from model mice.

Gyu-Hwan Park1, Shingo Kariya, Umrao R Monani.   

Abstract

Spinal muscular atrophy (SMA) is a common and often fatal neurodegenerative disease that primarily afflicts infants and young children. SMA is caused by abnormally low levels of the survival motor neuron (SMN) protein resulting from a combination of recessively inherited mutations in the SMN1 gene and the presence of an almost identical but partially functional copy gene, SMN2. Absence of the uniquely human SMN2 gene in SMA patients has never been reported because the SMN protein is indispensable for cell survival. Modeling SMA in animals therefore poses a challenge. This review describes the different strategies used to overcome this hurdle and model SMA in mice. We highlight new and emerging insights regarding SMA gained by studying the mice and illustrate how the animals serve as important tools to understand and eventually treat the human disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425235      PMCID: PMC2861773          DOI: 10.1007/s11910-010-0095-5

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  57 in total

1.  Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos.

Authors:  B Schrank; R Götz; J M Gunnersen; J M Ure; K V Toyka; A G Smith; M Sendtner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  The survival motor neuron protein in spinal muscular atrophy.

Authors:  D D Coovert; T T Le; P E McAndrew; J Strasswimmer; T O Crawford; J R Mendell; S E Coulson; E J Androphy; T W Prior; A H Burghes
Journal:  Hum Mol Genet       Date:  1997-08       Impact factor: 6.150

3.  The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis.

Authors:  U Fischer; Q Liu; G Dreyfuss
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

4.  The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins.

Authors:  Q Liu; U Fischer; F Wang; G Dreyfuss
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

5.  A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.

Authors:  U R Monani; C L Lorson; D W Parsons; T W Prior; E J Androphy; A H Burghes; J D McPherson
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

6.  Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.

Authors:  Markus Feldkötter; Verena Schwarzer; Radu Wirth; Thomas F Wienker; Brunhilde Wirth
Journal:  Am J Hum Genet       Date:  2001-12-21       Impact factor: 11.025

7.  Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.

Authors:  Luca Cartegni; Adrian R Krainer
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

8.  Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene.

Authors:  C J DiDonato; X N Chen; D Noya; J R Korenberg; J H Nadeau; L R Simard
Journal:  Genome Res       Date:  1997-04       Impact factor: 9.043

9.  A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing.

Authors:  L Pellizzoni; N Kataoka; B Charroux; G Dreyfuss
Journal:  Cell       Date:  1998-11-25       Impact factor: 41.582

10.  Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy.

Authors:  Matthew E R Butchbach; Jasbir Singh; Margrét Thorsteinsdóttir; Luciano Saieva; Elzbieta Slominski; John Thurmond; Thorkell Andrésson; Jun Zhang; Jonathan D Edwards; Louise R Simard; Livio Pellizzoni; Jill Jarecki; Arthur H M Burghes; Mark E Gurney
Journal:  Hum Mol Genet       Date:  2009-11-06       Impact factor: 6.150

View more
  33 in total

1.  Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.

Authors:  Tara L Martinez; Lingling Kong; Xueyong Wang; Melissa A Osborne; Melissa E Crowder; James P Van Meerbeke; Xixi Xu; Crystal Davis; Joe Wooley; David J Goldhamer; Cathleen M Lutz; Mark M Rich; Charlotte J Sumner
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

2.  Muscles in a mouse model of spinal muscular atrophy show profound defects in neuromuscular development even in the absence of failure in neuromuscular transmission or loss of motor neurons.

Authors:  Young Il Lee; Michelle Mikesh; Ian Smith; Mendell Rimer; Wesley Thompson
Journal:  Dev Biol       Date:  2011-05-30       Impact factor: 3.582

3.  Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics.

Authors:  Katherine V Bricceno; Tara Martinez; Evgenia Leikina; Stephanie Duguez; Terence A Partridge; Leonid V Chernomordik; Kenneth H Fischbeck; Charlotte J Sumner; Barrington G Burnett
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

4.  iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases.

Authors:  Chuang-Yu Lin; Michiko Yoshida; Li-Tzu Li; Akihiro Ikenaka; Shiori Oshima; Kazuhiro Nakagawa; Hidetoshi Sakurai; Eriko Matsui; Tatsutoshi Nakahata; Megumu K Saito
Journal:  JCI Insight       Date:  2019-09-19

5.  A cell-autonomous defect in skeletal muscle satellite cells expressing low levels of survival of motor neuron protein.

Authors:  Monica Hayhurst; Amanda K Wagner; Massimiliano Cerletti; Amy J Wagers; Lee L Rubin
Journal:  Dev Biol       Date:  2012-06-15       Impact factor: 3.582

Review 6.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

7.  Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation.

Authors:  Shingo Kariya; Teresa Obis; Caterina Garone; Turgay Akay; Fusako Sera; Shinichi Iwata; Shunichi Homma; Umrao R Monani
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

8.  SMN is required for sensory-motor circuit function in Drosophila.

Authors:  Wendy L Imlach; Erin S Beck; Ben Jiwon Choi; Francesco Lotti; Livio Pellizzoni; Brian D McCabe
Journal:  Cell       Date:  2012-10-12       Impact factor: 41.582

9.  Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy.

Authors:  Rachael A Powis; Thomas H Gillingwater
Journal:  J Anat       Date:  2015-11-17       Impact factor: 2.610

10.  Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy.

Authors:  Karen K Y Ling; Ming-Yi Lin; Brian Zingg; Zhihua Feng; Chien-Ping Ko
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.